PVLA

Palvella Therapeutics, Inc. Common Stock
PVLA

Overview Fund Activity

49 hedge funds and large institutions have $114M invested in Palvella Therapeutics, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+22
Holders Change %
+81.48%
% of All Funds
1.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
29
Increased
9
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BI
1
BVF Inc
California
$17.7M
2
BlackRock
2
BlackRock
New York
$7.52M
3
SSA
3
Schonfeld Strategic Advisors
New York
$4.1M
4
State Street
4
State Street
Massachusetts
$2.38M
5
Northern Trust
5
Northern Trust
Illinois
$1.63M

Top Sellers

1
LOAMU
1
Lombard Odier Asset Management (USA)
New York
$6.88M
2
TCM
2
Tekla Capital Management
Massachusetts
$14.4M
3
OFM
3
Omega Fund Management
Massachusetts
$6.92M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$586K
5
DCM
5
DAFNA Capital Management
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Walleye Trading
51
Walleye Trading
New York
– -$37 -176 Closed
UBS Group
52
UBS Group
Switzerland
– -$4K -20 Closed
TRCT
53
Tower Research Capital (TRC)
New York
– -$1K -3 Closed
1 2
3